Publications:

---

Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma.

Frontiers In Genetics

Zheng, Hongyan H; Guo, Xiaorong X; Li, Nan N; Qin, Luyao L; Li, Xiaoqing X; Lou, Ge G

Publication Date: 2022

Variant appearance in text: HER-2: A21D

PubMed Link: 36159998

Variant Present in the following documents:

• DataSheet7.xlsx, sheet 1

View BVdb publication page

---

Genetic fusions favor tumorigenesis through degron loss in oncogenes.

Nature Communications

Liu, Jing J; Tokheim, Collin C; Lee, Jonathan D JD; Gan, Wenjian W; North, Brian J BJ; Liu, X Shirley XS; Pandolfi, Pier Paolo PP; Wei, Wenyi W

Publication Date: 2021-11-18

Variant appearance in text: ERBB2: A21D

PubMed Link: 34795215

Variant Present in the following documents:

• 41467_2021_26871_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.

Theranostics

Shi, Zhiwen Z; Shen, Jianfeng J; Qiu, Junjun J; Zhao, Qingguo Q; Hua, Keqin K; Wang, Hongyan H

Publication Date: 2021

Variant appearance in text: HER2: a21d

PubMed Link: 34158843

Variant Present in the following documents:

• thnov11p7175s1.xlsx, sheet 1

View BVdb publication page

---

Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study.

Breast Cancer Research : Bcr

Alhareeri, Areej A AA; Archer, Kellie J KJ; Fu, Han H; Lyon, Debra E DE; Elswick, R K RK; Kelly, Debra L DL; Starkweather, Angela R AR; Elmore, Lynne W LW; Bokhari, Yahya A YA; Jackson-Cook, Colleen K CK

Publication Date: 2020-12-04

Variant appearance in text: HER2: A21D

PubMed Link: 33276807

Variant Present in the following documents:

• Main text

View BVdb publication page

---

ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.

Peerj

Luo, Juan J; Zeng, Beilei B; Tao, Chunfang C; Lu, Mengqi M; Ren, Guosheng G

Publication Date: 2020

Variant appearance in text: HER2: a21d

PubMed Link: 32195060

Variant Present in the following documents:

• peerj-08-8754-s034.xlsx, sheet 3
• peerj-08-8754-s034.xlsx, sheet 2

View BVdb publication page

---

MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1.

Frontiers In Genetics

Lin, Xiao X; Qiu, Wuxia W; Xiao, Yunyun Y; Ma, Jianhua J; Xu, Fang F; Zhang, Kewen K; Gao, Yongguang Y; Chen, Qiang Q; Li, Yu Y; Li, Hui H; Qian, Airong A

Publication Date: 2019

Variant appearance in text: HER2: a21d

PubMed Link: 32082362

Variant Present in the following documents:

• Table_2.xlsx, sheet 1

View BVdb publication page

---

Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.

Scientific Reports

Kiss, Bernhard B; Wyatt, Alexander W AW; Douglas, James J; Skuginna, Veronika V; Mo, Fan F; Anderson, Shawn S; Rotzer, Diana D; Fleischmann, Achim A; Genitsch, Vera V; Hayashi, Tetsutaro T; Neuenschwander, Maja M; Buerki, Christine C; Davicioni, Elai E; Collins, Colin C; Thalmann, George N GN; Black, Peter C PC; Seiler, Roland R

Publication Date: 2017-02-16

Variant appearance in text: ERBB2: A21D

PubMed Link: 28205537

Variant Present in the following documents:

View BVdb publication page

---